{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:29:54Z","timestamp":1789680594564,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["201865006.028.111"],"award-info":[{"award-number":["201865006.028.111"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Multiple medication safety recommendations to reduce preventable medication-related hospitalisations have been introduced in the Netherlands. Still, these hospitalisations remain prevalent. This might be due to suboptimal implementation in clinical practice. Therefore, more insight is needed into barriers and facilitators for the implementation of these medication safety recommendations across healthcare sectors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to identify barriers and facilitators for implementing medication safety recommendations across healthcare sectors from the perspective of various stakeholders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A selection of 17 Dutch medication safety recommendations targeting medications responsible for a large proportion of medication-related hospitalisations was evaluated in focus groups to identify barriers and facilitators to their implementation. These included recommendations for: reducing fall risk in elderly; initiating prophylactic medication; monitoring patients at risk of electrolyte disorders; clarifying responsibilities for patient care; informing patients about alarm symptoms; and prescribing antithrombotics on strict indication. Stakeholders were selected through purposive sampling based on their profession and healthcare sector. Transcripts of audio-recordings were analysed inductively, after which implementation factors were categorised using the Consolidated Framework for Implementation Research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty stakeholders were divided into five focus groups. These included community pharmacists (n\u2009=\u20099), general practitioners (n\u2009=\u20094), hospital pharmacists (n\u2009=\u20093), representatives from healthcare knowledge organisations (n\u2009=\u20093), patient representatives (n\u2009=\u20092), medical specialists (n\u2009=\u20092), nurses (n\u2009=\u20092), and other stakeholders (n\u2009=\u20095). Forty-nine barriers and facilitators were identified. Key themes were lack of specified responsibilities, limited information exchange, local collaboration and protocol adherence. Recommendations with a lower level of implementation often required collaboration with multiple healthcare providers, whereas recommendations with a higher level of implementation were frequently supported by clinical decision support systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A broad range of barriers and facilitators to the implementation of medication safety recommendations was identified. Overall, the findings highlight the need for recommendations with specified responsibilities, improved information exchange, strengthened local collaboration, and increased protocol adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02141-z","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:18:00Z","timestamp":1777547880000},"page":"1607-1621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Barriers and facilitators for the implementation of medication safety recommendations: focus groups with stakeholders"],"prefix":"10.1007","volume":"48","author":[{"given":"Mirthe A. M.","family":"Oude Lansink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"van Tholen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Dankers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Heringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liset","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J. B.","family":"Huiskes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2141_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2017-000264","volume":"8","author":"A Smeraglio","year":"2019","unstructured":"Smeraglio A, Heidenreich PA, Krishnan G, et al. Patient vs provider perspectives of 30-day hospital readmissions. BMJ Open Qual. 2019;8:e000264. https:\/\/doi.org\/10.1136\/bmjoq-2017-000264.","journal-title":"BMJ Open Qual"},{"key":"2141_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jval.2010.10.024","volume":"14","author":"AJ Leendertse","year":"2011","unstructured":"Leendertse AJ, Van Den Bemt PMLA, Poolman JB, et al. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health. 2011;14:34\u201340. https:\/\/doi.org\/10.1016\/j.jval.2010.10.024.","journal-title":"Value Health"},{"key":"2141_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/jgs.15244","volume":"66","author":"N El Morabet","year":"2018","unstructured":"El Morabet N, Uitvlugt EB, van den Bemt BJF, et al. Prevalence and preventability of drug\u2010related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66:602\u20138. https:\/\/doi.org\/10.1111\/jgs.15244.","journal-title":"J Am Geriatr Soc"},{"key":"2141_CR4","unstructured":"Sturkenboom M, Erasmus MC, NIVEL, et al. Vervolgonderzoek medicatieveiligheid (Follow-up report medication safety). 2017 Jan."},{"key":"2141_CR5","unstructured":"Expertgroep medicatieveiligheid (Expert group medication safety). Harm-Wrestling report. 2008."},{"key":"2141_CR6","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1001\/archinternmed.2008.3","volume":"168","author":"AJ Leendertse","year":"2008","unstructured":"Leendertse AJ, Egberts ACG, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890\u20136. https:\/\/doi.org\/10.1001\/archinternmed.2008.3.","journal-title":"Arch Intern Med"},{"key":"2141_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/11596000-000000000-00000","volume":"35","author":"MF Warl\u00e9-van Herwaarden","year":"2012","unstructured":"Warl\u00e9-van Herwaarden MF, Kramers C, Sturkenboom MC, et al. Targeting outpatient drug safety. Drug Saf. 2012;35:245\u201359. https:\/\/doi.org\/10.2165\/11596000-000000000-00000.","journal-title":"Drug Saf"},{"key":"2141_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.sapharm.2016.08.005","volume":"13","author":"N Jokanovic","year":"2017","unstructured":"Jokanovic N, Tan ECK, Sudhakaran S, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Soc Adm Pharm. 2017;13:661\u201385. https:\/\/doi.org\/10.1016\/j.sapharm.2016.08.005.","journal-title":"Res Soc Adm Pharm"},{"key":"2141_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pec.2020.07.026","volume":"104","author":"V Shersher","year":"2021","unstructured":"Shersher V, Haines TP, Sturgiss L, et al. Definitions and use of the teach-back method in healthcare consultations with patients: a systematic review and thematic synthesis. Patient Educ Couns. 2021;104:118\u201329. https:\/\/doi.org\/10.1016\/j.pec.2020.07.026.","journal-title":"Patient Educ Couns"},{"key":"2141_CR10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s11096-025-02031-w","volume":"47","author":"AS Doherty","year":"2025","unstructured":"Doherty AS, Adamson G, Mallett J, et al. Addressing potentially inappropriate prescribing in care homes: regional evaluation of a pharmacist-led model in Northern Ireland. Int J Clin Pharm. 2025;47:2061\u201371. https:\/\/doi.org\/10.1007\/s11096-025-02031-w.","journal-title":"Int J Clin Pharm"},{"key":"2141_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2710.2007.00867.x","volume":"32","author":"AP Tonna","year":"2007","unstructured":"Tonna AP, Stewart D, West B, et al. Pharmacist prescribing in the UK \u2013 a literature review of current practice and research. J Clin Pharm Ther. 2007;32:545\u201356. https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00867.x.","journal-title":"J Clin Pharm Ther"},{"key":"2141_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s11096-016-0301-x","volume":"38","author":"M Teichert","year":"2016","unstructured":"Teichert M, Schoenmakers T, Kylstra N, et al. Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies. Int J Clin Pharm. 2016;38:870\u20139. https:\/\/doi.org\/10.1007\/s11096-016-0301-x.","journal-title":"Int J Clin Pharm"},{"key":"2141_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/ejhpharm-2023-003857","volume":"31","author":"E Johns","year":"2024","unstructured":"Johns E, Alkanj A, Beck M, et al. Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review. Eur J Hosp Pharm. 2024;31:289\u201394. https:\/\/doi.org\/10.1136\/ejhpharm-2023-003857.","journal-title":"Eur J Hosp Pharm"},{"key":"2141_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.18773\/austprescr.2023.010","volume":"46","author":"E Su","year":"2023","unstructured":"Su E, Liew DF, Donnelly J, et al. Medicines stewardship. Aust Prescr. 2023;46:24\u20138. https:\/\/doi.org\/10.18773\/austprescr.2023.010.","journal-title":"Aust Prescr"},{"key":"2141_CR15","unstructured":"World Health Organization. Medication without harm - global patient safety challenge on medication safety. Geneva. 2017"},{"key":"2141_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. https:\/\/doi.org\/10.1186\/1748-5908-4-50.","journal-title":"Implement Sci"},{"key":"2141_CR17","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/PTS.0000000000000248","volume":"16","author":"S Kattel","year":"2020","unstructured":"Kattel S, Manning DM, Erwin PJ, et al. Information transfer at hospital discharge: a systematic review. J Patient Saf. 2020;16:e25-33. https:\/\/doi.org\/10.1097\/PTS.0000000000000248.","journal-title":"J Patient Saf"},{"key":"2141_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.297.8.831","volume":"297","author":"S Kripalani","year":"2007","unstructured":"Kripalani S, LeFevre F, Phillips CO, et al. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297:831\u201341. https:\/\/doi.org\/10.1001\/jama.297.8.831.","journal-title":"JAMA"},{"key":"2141_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-3-56","volume":"3","author":"TK Nuckols","year":"2014","unstructured":"Nuckols TK, Smith-Spangler C, Morton SC, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev. 2014;3:56. https:\/\/doi.org\/10.1186\/2046-4053-3-56.","journal-title":"Syst Rev"},{"key":"2141_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009985.pub2","author":"A Ciapponi","year":"2021","unstructured":"Ciapponi A, Fernandez Nievas SE, Seijo M, et al. Reducing medication errors for adults in hospital settings. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD009985.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2141_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"2141_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, et al. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17:75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0.","journal-title":"Implement Sci"},{"key":"2141_CR23","unstructured":"CCMO Central Committee on Research Involving Human Subjects. Your research: subject to the WMO or not? https:\/\/english.ccmo.nl\/investigators\/legal-framework-for-medical-scientific-research\/your-research-is-it-subject-to-the-wmo-or-not. Accessed 27.01.2026"},{"key":"2141_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/jcpt.13645","volume":"47","author":"S En-Nasery-de Heer","year":"2022","unstructured":"En-Nasery-de Heer S, Uitvlugt EB, Bet PM, et al. Implementation of a pharmacist-led transitional pharmaceutical care programme: process evaluation of medication actions to reduce hospital admissions through a collaboration between community and hospital pharmacists (MARCH). J Clin Pharm Ther. 2022;47:1049\u201369. https:\/\/doi.org\/10.1111\/jcpt.13645.","journal-title":"J Clin Pharm Ther"},{"key":"2141_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167683","volume":"11","author":"P Jia","year":"2016","unstructured":"Jia P, Zhang L, Chen J, et al. The effects of clinical decision support systems on medication safety: an overview. PLoS ONE. 2016;11:e0167683. https:\/\/doi.org\/10.1371\/journal.pone.0167683.","journal-title":"PLoS ONE"},{"key":"2141_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/14604582211007536","author":"OO Olakotan","year":"2021","unstructured":"Olakotan OO, Mohd Yusof M. The appropriateness of clinical decision support systems alerts in supporting clinical workflows: a systematic review. Health Informatics J. 2021. https:\/\/doi.org\/10.1177\/14604582211007536.","journal-title":"Health Informatics J"},{"key":"2141_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-26","volume":"6","author":"AR Gagliardi","year":"2011","unstructured":"Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011;6:26. https:\/\/doi.org\/10.1186\/1748-5908-6-26.","journal-title":"Implement Sci"},{"key":"2141_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-016-0440-4","volume":"11","author":"Z Wang","year":"2015","unstructured":"Wang Z, Norris SL, Bero L. Implementation plans included in World Health Organisation guidelines. Implement Sci. 2015;11:76. https:\/\/doi.org\/10.1186\/s13012-016-0440-4.","journal-title":"Implement Sci"},{"key":"2141_CR29","unstructured":"Zorginstituut Nederland (National Healthcare Institute). Wegiz: elektronische gegevensuitwisseling (electronic data exchange). 2023 https:\/\/www.zorginzicht.nl\/ondersteuning\/wet-elektronische-gegevensuitwisseling-in-de-zorg-wegiz. Accessed 23.07.2025"},{"key":"2141_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-019-0892-4","volume":"14","author":"TJ Waltz","year":"2019","unstructured":"Waltz TJ, Powell BJ, Fern\u00e1ndez ME, et al. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 2019;14:42. https:\/\/doi.org\/10.1186\/s13012-019-0892-4.","journal-title":"Implement Sci"},{"key":"2141_CR31","unstructured":"Lambooij M, Molema C, Limburg L, et al. Inventarisatie initiatieven medicatieveiligheid: Relatie met Harm-Wrestling aanbevelingen (Inventory of medication safety initiatives: relation to the Harm-Wrestling recommendations). 2012"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02141-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02141-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02141-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:31:09Z","timestamp":1784035869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02141-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02141-z","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"No ethical approval was required for this study as no risk was involved with participation, no patients were involved and no personal or identifiable data from participants were collected. Stakeholders signed informed consent after receiving written information about the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all stakeholders included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}